3004.90.92.20/Hydralazine 50mg Extended-Release Tablets/Japan

Hydralazine 50mg Extended-Release Tablets from Japan

Extended-release tablets providing 50mg hydralazine for once-daily dosing in managing chronic hypertension. Falls under HTS 3004.90.92.20 as a mixed product in measured doses for therapeutic cardiovascular use, put up for retail sale.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Verify extended-release mechanism compliance with FDA dissolution testing standards

• Provide detailed formulation specs including excipients to avoid reclassification as bulk chemical